{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T17:00:00Z","timestamp":1773075600094,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T00:00:00Z","timestamp":1693440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T00:00:00Z","timestamp":1693440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005765","name":"Universidade de Lisboa","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005765","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Early death (ED) is still the major obstacle to cure in acute promyelocytic leukemia (APL). Most studies focus on 30-day ED; however, little is known on predictors of death before starting APL treatment (very early death \u2014 VED) and on predictors of 7-day ED, the period with most deaths due to thrombohemorrhagic diathesis. We hypothesized whether the severity of the coagulopathy of APL could predict VED and 7-day ED. We also aimed to evaluate other characteristics associated with these outcomes. We undertook a retrospective, single-center observational study including newly diagnosed APL patients admitted to our institution between January 2000 and November 2022. Baseline demographical, clinical, and laboratorial data were collected. Statistical analysis was performed using Stata. One hundred four patients were included. The VED rate was 4.8%. A DIC Score\u2009\u2265\u20097 (<jats:italic>p<\/jats:italic>\u2009=\u20090.045), serum creatinine\u2009&gt;\u20091.5\u00a0mg\/dL (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001%), a DIC Score\u2009\u2265\u20096 within 24\u00a0h (<jats:italic>p<\/jats:italic>\u2009=\u20090.009), and mechanical ventilation (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) were associated with VED. The 7-day ED rate was 12.5%. High-risk (<jats:italic>p<\/jats:italic>\u2009=\u20090.007) and hypogranular APL (<jats:italic>p<\/jats:italic>\u2009=\u20090.029), DIC Score at diagnosis (<jats:italic>p<\/jats:italic>\u2009=\u20090.047), DIC Score\u2009\u2265\u20097 (<jats:italic>p<\/jats:italic>\u2009=\u20090.043), DIC Score\u2009\u2265\u20096 within 24\u00a0h (<jats:italic>p<\/jats:italic>\u2009=\u20090.025), PT prolongation\u2009&gt;\u20096\u00a0s (<jats:italic>p<\/jats:italic>\u2009=\u20090.002), and creatinine\u2009&gt;\u20091.5\u00a0mg\/dL (<jats:italic>p<\/jats:italic>\u2009=\u20090.004) were associated with 7-day ED. However, only elevated creatinine emerged as an independent predictor of 7-day ED (OR 21.4; <jats:italic>p<\/jats:italic>\u2009=\u20090.008). Our study shows that in patients with APL, an elevated creatinine at diagnosis strongly predicts for 7-day ED. A DIC Score\u2009\u2265\u20097 and a Score that remains\u2009\u2265\u20096 within 24\u00a0h and a serum creatinine\u2009&gt;\u20091.5\u00a0mg\/dL significantly associated with VED.<\/jats:p>","DOI":"10.1007\/s00277-023-05422-z","type":"journal-article","created":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T09:02:23Z","timestamp":1693472543000},"page":"3031-3037","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Predictors of very early death in acute promyelocytic leukemia: a retrospective real-world cohort study"],"prefix":"10.1007","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4505-2299","authenticated-orcid":false,"given":"Joana","family":"Infante","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gra\u00e7a","family":"Esteves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o","family":"Raposo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o Forjaz","family":"de Lacerda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,31]]},"reference":[{"issue":"13","key":"5422_CR1","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.1080\/10428194.2019.1613540","volume":"60","author":"M Stahl","year":"2019","unstructured":"Stahl M, Tallman MS (2019) Acute promyelocytic leukemia (APL): remaining challenges towards a cure for all. Leuk Lymphoma 60(13):3107\u20133115","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"5422_CR2","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1300874","volume":"369","author":"F Lo-Coco","year":"2013","unstructured":"Lo-Coco F, Avvisati G, Vignetti M, Thiede C, Orlando SM, Iacobelli S et al (2013) Retinoic acid and arsenic trioxide for acute promyelocytic leukemia. N Engl J Med 369(2):111\u2013121","journal-title":"N Engl J Med"},{"issue":"12","key":"5422_CR3","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1038\/leu.2009.183","volume":"23","author":"E Lengfelder","year":"2009","unstructured":"Lengfelder E, Haferlach C, Saussele S, Haferlach T, Schultheis B, Schnittger S et al (2009) High dose ara-C in the treatment of newly diagnosed acute promyelocytic leukemia: long-term results of the German AMLCG. Leukemia 23(12):2248\u20132258","journal-title":"Leukemia"},{"issue":"7","key":"5422_CR4","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/leu.2011.78","volume":"25","author":"S Lehmann","year":"2011","unstructured":"Lehmann S, Ravn A, Carlsson L, Antunovic P, Deneberg S, M\u00f6llgrd L et al (2011) Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry. Leukemia 25(7):1128\u20131134","journal-title":"Leukemia"},{"key":"5422_CR5","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.3324\/haematol.10874","volume":"92","author":"RH J\u00e1como","year":"2007","unstructured":"J\u00e1como RH, Melo RAM, Souto FR, de Mattos ER, de Oliveira CT, Fagundes EM et al (2007) Clinical features and outcomes of 134 Brazilians with acute promyelocytic leukemia who received ATRA and anthracyclines. Haematologica Italy 92:1431\u20132","journal-title":"Haematologica Italy"},{"issue":"6","key":"5422_CR6","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.ejca.2013.11.023","volume":"50","author":"JB Micol","year":"2014","unstructured":"Micol JB, Raffoux E, Boissel N, Lenglin\u00e9 E, Canet E, Daniel MT et al (2014) Management and treatment results in patients with acute promyelocytic leukaemia (APL) not enrolled in clinical trials. Eur J Cancer 50(6):1159\u20131168","journal-title":"Eur J Cancer"},{"issue":"7","key":"5422_CR7","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.1182\/blood-2007-07-100669","volume":"111","author":"J de la Serna","year":"2008","unstructured":"de la Serna J, Montesinos P, Vellenga E, Ray\u00f3n C, Parody R, Le\u00f3n A et al (2008) Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin. Blood 111(7):3395\u20133402","journal-title":"Blood"},{"key":"5422_CR8","doi-asserted-by":"crossref","unstructured":"Brioso Infante J, Esteves G, Martins H, Medeiros J, Alves D, Lopes C et al (2020) Disseminated Intravascular Coagulation Score evolution in 48 hours predicts early death in newly-diagnosed chemotherapy-treated acute promyelocytic leukemia patients. Blood [Internet]. 136:9. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0006497118702401. Accessed 19 July 2023","DOI":"10.1182\/blood-2020-143138"},{"issue":"15","key":"5422_CR9","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1182\/blood-2019-01-894980","volume":"133","author":"MA Sanz","year":"2019","unstructured":"Sanz MA, Fenaux P, Tallman MS, Estey EH, L\u00f6wenberg B, Naoe T et al (2019) Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet. Blood 133(15):1630\u20131643","journal-title":"Blood"},{"issue":"3","key":"5422_CR10","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1111\/j.1538-7836.2007.02313.x","volume":"5","author":"CH Toh","year":"2007","unstructured":"Toh CH, Hoots WK (2007) The scoring system of the scientific and standardisation committee on disseminated intravascular coagulation of the international society on thrombosis and Haemostasis: a 5-year overview. J Thromb Haemost 5(3):604\u2013606","journal-title":"J Thromb Haemost"},{"key":"5422_CR11","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12959-018-0168-2","volume":"16","author":"H Wada","year":"2018","unstructured":"Wada H, Matsumoto T, Suzuki K, Imai H, Katayama N, Iba T et al (2018) Differences and similarities between disseminated intravascular coagulation and thrombotic microangiopathy. Thromb J 16:14","journal-title":"Thromb J"},{"issue":"7","key":"5422_CR12","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/leu.2011.78","volume":"25","author":"S Lehmann","year":"2011","unstructured":"Lehmann S, Ravn A, Carlsson L, Antunovic P, Deneberg S, M\u00f6llg\u00e5rd L et al (2011) Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the swedish adult acute leukemia registry. Leukemia 25(7):1128\u20131134","journal-title":"Leukemia"},{"issue":"5","key":"5422_CR13","doi-asserted-by":"publisher","first-page":"853","DOI":"10.3324\/haematol.2009.017962","volume":"95","author":"M Breccia","year":"2010","unstructured":"Breccia M, Latagliata R, Cannella L, Minotti C, Meloni G, Lo-Coco F (2010) Early hemorrhagic death before starting therapy in acute promyelocytic leukemia: association with high white blood cell count, late diagnosis and delayed treatment initiation. Haematologica 95(5):853\u2013854","journal-title":"Haematologica"},{"issue":"2","key":"5422_CR14","doi-asserted-by":"publisher","first-page":"e116","DOI":"10.1016\/j.clml.2018.11.004","volume":"19","author":"WF da Silva","year":"2019","unstructured":"da Silva WF, da Rosa LI, Marquez GL, Bassolli L, Tucunduva L, Silveira DRA et al (2019) Real-life outcomes on acute promyelocytic leukemia in Brazil - early deaths are still a problem. Clin Lymphoma Myeloma Leuk. 19(2):e116-22","journal-title":"Clin Lymphoma Myeloma Leuk."},{"issue":"1","key":"5422_CR15","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.beha.2008.12.007","volume":"22","author":"E Stein","year":"2009","unstructured":"Stein E, McMahon B, Kwaan H, Altman JK, Frankfurt O, Tallman MS (2009) The coagulopathy of acute promyelocytic leukaemia revisited. Best Pract Res Clin Haematol [Internet]. 22(1):153\u201363. https:\/\/doi.org\/10.1016\/j.beha.2008.12.007","journal-title":"Best Pract Res Clin Haematol [Internet]."},{"issue":"45","key":"5422_CR16","first-page":"1944","volume":"126","author":"MJ Bargetzi","year":"1996","unstructured":"Bargetzi MJ, Tichelli A, Gratwohl A, Speck B (1996) Oral All-transretinoic acid administration in intubated patients with acute promyelocytic leukemia. Schweiz Med Wochenschr 126(45):1944\u20131945","journal-title":"Schweiz Med Wochenschr"},{"issue":"7","key":"5422_CR17","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1177\/1078155221990091","volume":"27","author":"DJ Przybylski","year":"2021","unstructured":"Przybylski DJ, Jared JR, Fallon MJ (2021) Extemporaneous compounding and administration of tretinoin slurry for acute promyelocytic leukemia. J Oncol Pharm Pract Off Publ Int Soc Oncol Pharm Pract 27(7):1779\u20131783","journal-title":"J Oncol Pharm Pract Off Publ Int Soc Oncol Pharm Pract"},{"issue":"1","key":"5422_CR18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1182\/blood.V97.1.73","volume":"97","author":"D Douer","year":"2001","unstructured":"Douer D, Estey E, Santillana S, Bennett JM, Lopez-Bernstein G, Boehm K et al (2001) Treatment of newly diagnosed and relapsed acute promyelocytic leukemia with intravenous liposomal all-trans retinoic acid. Blood 97(1):73\u201380","journal-title":"Blood"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05422-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-023-05422-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05422-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T10:17:21Z","timestamp":1697019441000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-023-05422-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,31]]},"references-count":18,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["5422"],"URL":"https:\/\/doi.org\/10.1007\/s00277-023-05422-z","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,31]]},"assertion":[{"value":"9 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was waived by the local Ethics Committee of Centro Acad\u00e9mico de Medicina de Lisboa in view of the retrospective nature of the study and all the procedures being performed were part of the routine care.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}